Holland Orthopaedic & Arthritic Centre, Sunnybrook Health Sciences Centre, 43 Wellesley Street East, Toronto, Ontario, Canada.
Bone Joint J. 2013 Aug;95-B(8):1040-4. doi: 10.1302/0301-620X.95B8.31574.
We prospectively assessed the efficacy of a ceramic-on-metal (CoM) hip bearing with uncemented acetabular and femoral components in which cobalt-chrome acetabular liners and alumina ceramic heads were used. The cohort comprised 94 total hip replacements (THRs) in 83 patients (38 women and 45 men) with a mean age of 58 years (42 to 70). Minimum follow-up was two years. All patients had pre- and post-operative assessment using the Western Ontario and McMaster Universities osteoarthritis index (WOMAC), Oxford hip score and Short-Form 12 scores. All showed a statistically significant improvement from three months post-operatively onwards (all p < 0.001). After two years whole blood metal ion levels were measured and chromosomal analysis was performed. The levels of all metal ions were elevated except vanadium. Levels of chromium, cobalt, molybdenum and titanium were significantly higher in patients who underwent bilateral THR compared with those undergoing unilateral THR (p < 0.001). Chromosomal analysis demonstrated both structural and aneuploidy mutations. There were significantly more breaks and losses than in the normal population (p < 0.001). There was no significant difference in chromosomal aberration between those undergoing unilateral and bilateral procedures (all analyses p ≥ 0.62). The use of a CoM THR is effective clinically in the short-term, with no concerns, but the significance of high metal ion levels and chromosomal aberrations in the long-term remains unclear.
我们前瞻性评估了使用非骨水泥髋臼和股骨组件的陶瓷对金属(CoM)髋关节假体的疗效,其中钴铬髋臼衬垫和氧化铝陶瓷头。该队列包括 83 名患者(38 名女性和 45 名男性)的 94 例全髋关节置换术(THR),平均年龄为 58 岁(42 至 70 岁)。最小随访时间为两年。所有患者均使用 Western Ontario 和 McMaster 大学骨关节炎指数(WOMAC)、牛津髋关节评分和简短表格 12 评分进行术前和术后评估。所有患者在术后三个月开始均显示出统计学显著改善(均 p < 0.001)。两年后测量全血金属离子水平并进行染色体分析。除钒外,所有金属离子水平均升高。双侧 THR 患者的铬、钴、钼和钛水平明显高于单侧 THR 患者(p < 0.001)。染色体分析显示结构和非整倍体突变。与正常人群相比,断裂和丢失明显更多(p < 0.001)。单侧和双侧手术之间的染色体异常没有显著差异(所有分析 p ≥ 0.62)。在短期内,使用 CoM THR 在临床上是有效的,没有问题,但长期高金属离子水平和染色体异常的意义仍不清楚。